Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 91Observational 5

Sponsor

Cancer Type

Thoracic 5Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 30Carcinoma, Non-Small-Cell Lung 9Carcinoma, Hepatocellular 7Breast Neoplasms 7Carcinoma, Renal Cell 6Lung Neoplasms 5Ovarian Neoplasms 4Colorectal Cancer Metastatic 3Colonic Neoplasms 3Adenocarcinoma of Lung 3Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Financial Stress 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable Hepatocellular Carcinoma 1Surgical Wound Infection 1Non-Squamous Non-Small Cell Lung Cancer 1Neuroma, Acoustic 1Neurofibromatosis 2 1NSCLC 1Melanoma 1Kidney Neoplasms 1Hypertension 1Hemorrhage 1Glioblastoma 1Feasibility 1

Interventions

Blood Specimen Collection 32Surveys and Questionnaires 24Radiotherapy 12Gene Expression Profiling 12Drug Therapy 12Surgical Procedures, Operative 11Bronchoscopy 10Magnetic Resonance Spectroscopy 9Immunotherapy 9Immunohistochemistry 9Tomography, X-Ray Computed 8Specimen Handling 8Observation 8Amplified Fragment Length Polymorphism Analysis 8Polymerase Chain Reaction 7pembrolizumab 6Psychiatric Rehabilitation 6Interviews as Topic 6Carboplatin 6Thoracic Surgery, Video-Assisted 5Reverse Transcriptase Polymerase Chain Reaction 5Microarray Analysis 5Liquid Biopsy 5Chemoradiotherapy 5Bevacizumab 5durvalumab 4Therapeutics 4Paclitaxel 4Nivolumab 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Lung Neoplasms × Bevacizumab × Clear all
NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

Cambridge University Hospitals NHS Foundation Trust

Unknown
1,800 enrolled
DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT04788381 2021-03-09

The Effects of Preoperative Bevacizumab on Perioperative Complications

Second Affiliated Hospital, School of Medicine, Zhejiang University

Unknown
100 enrolled
GastrointestinalThoracic

Lung Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

NCT02745691 2019-12-13

Psychometric Properties of the EORTC QLQ-LC29

University Hospital Regensburg

Completed
523 enrolled
Thoracic

Lung Neoplasms

NCT00898417 2017-05-19

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

Eastern Cooperative Oncology Group

Completed
90 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡